Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space

#COVID19-induced ARDS is partly explained by the presence of microthrombi, motivating the use of thrombolytics. This study shows that thrombolytics decrease dead space ventilation in COVID-19 ARDS patients. https://bit.ly/2GdM44a

Detalles Bibliográficos
Autores principales: Orfanos, Sarah, El Husseini, Ibrahim, Nahass, Thomas, Radbel, Jared, Hussain, Sabiha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Original Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533378/
https://www.ncbi.nlm.nih.gov/pubmed/33043052
http://dx.doi.org/10.1183/23120541.00455-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533378/
https://www.ncbi.nlm.nih.gov/pubmed/33043052
http://dx.doi.org/10.1183/23120541.00455-2020

Ejemplares similares